START trial finds that early treatment improves outcomes for people with HIV
High lifetime costs of treating HIV show importance of investing in prevention
Acute HIV infection may present in many ways – sometimes as a serious illness
Funders' priorities and targets hindered community mobilisation and meaningful participation of sex workers in India
Lower daily tenofovir dose of 150mg safe and effective in people with moderate renal impairment
Hepatitis C treatment for people in prison may be highly cost-effective in England
Prioritisation is crucial for the success of PrEP, model confirms
Statin use associated with lower risk of liver decompensation and death in hepatitis C patients with cirrhosis
